The PI3K/mTOR signaling pathway is one of the most frequently disrupted intracellular pathways in human cancer, where it contributes significantly to tumor progression and development of resistance to chemotherapeutic drugs [4, 5]. This evidence concerns the gene MTOR and neoplasm.